Laboratory record
Resolian
Peptide bioanalysis by LC-MS/MS, with published methods quantifying peptides in plasma to as low as 10 pg/mL and high-resolution MS for degradation product identification. Formerly Alliance Pharma; the Malvern site is described as the original 2008 location.
Malvern, Pennsylvania, United States
Published capabilities
Recorded from the laboratory’s own live pages. “Not stated” means the laboratory has not published a position — it is not a statement that the service is unavailable.
- Peptide-specific testing
- Yes
- HPLC
- Not stated
- LC-MS
- Yes
- Mass spectrometry
- Yes
- Identity
- Not stated
- Purity
- Not stated
- Amino acid analysis
- Not stated
- Endotoxin
- Not stated
- Sterility
- Not stated
Accreditation and working terms
- Accreditation
- Self-reported: the Malvern facility is described as “GxP-compliant and Gyrolab-certified”, with method development and validation for GLP toxicokinetic studies and GCP clinical trials.Self-reported
- Turnaround time
- Not publicly stated
- Sample requirements
- Not publicly stated
- Report policy
- Not publicly stated — contract model, reports to the client.
Sources
- Resolian — peptide analysisCapabilities, facility claims and the Alliance Pharma name change read from the live pages on 3 September 2026.
Last reviewed 3 September 2026 · Report an inaccuracy in this record